Form 4: CareDx Director Receives Stock Grant
Statement of Changes in Beneficial Ownership
Michael Goldberg, a Director at CareDx, Inc., received a quarterly stock grant of 1,981 shares as compensation.
Summary
- Michael Goldberg, a Director at CareDx, Inc., was granted 1,981 shares of common stock on April 2, 2026.
- This grant is part of the company's Outside Director Compensation Policy, where directors receive stock in lieu of cash compensation.
- The shares were automatically granted on a quarterly basis.
- Following this transaction, Mr. Goldberg beneficially owns 185,942 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation event for a director rather than a significant strategic or financial development.
Positives
- Director compensation is being paid in stock, aligning director interests with shareholders.
- Automatic quarterly grants ensure consistent compensation for directors.
Future Outlook
No specific future outlook or guidance is provided in this filing.
Industry Context
StockSavvy.ai notes that the use of stock grants for director compensation is a common practice in the biotechnology and healthcare sectors, aiming to align executive and director incentives with long-term shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy | Automatic quarterly grant of common stock to a non-employee director in lieu of cash compensation. | Ongoing | Reinforces alignment of director interests with shareholders and provides a consistent compensation structure. |
Stakeholder Impact
- Shareholders: The use of stock for director compensation aligns director interests with shareholder value creation.
- Directors: Provides compensation in the form of company stock, subject to market fluctuations.
- Employees: No direct impact, but reflects company policy on executive and director compensation.
Key Dates
| Date | Description |
|---|---|
| 04/02/2026 | Transaction Date (Stock grant received by Michael Goldberg) |
| 04/03/2026 | Date of Report |
Keywords
Form 4, SEC Filing, CareDx, CDNA, Director Compensation, Stock Grant, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.